This is a preview of subscription content, log in via an institution to check access.
References
Lohmann V, Korner F, Koch J, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110–3
Bukh J, Pietschmann T, Lohmann V. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A 2002; 99 (22): 14416–21
Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309: 623–6
Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791–6
Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 2005; 102: 9294–9
Mercer DF, Schiller DE, Elliot JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001; 7: 927–33
Lamarre D, Anderson PC, Bailey M. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 2003; 426: 186–9
Rights and permissions
About this article
Cite this article
Pharmacotherapy for a Phantom Menace. Pharmaceutical & Diagnostic Innovation 4, 8–13 (2006). https://doi.org/10.1007/BF03257051
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257051